[Protein kinase C beta-Inhibitor ruboxistaurin].
Musch
Annemarie
A
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D003929:Diabetic Neuropathies / Q000188:drug therapy*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008301:Maleimides / Q000627:therapeutic use*; D011493:Protein Kinase C / Q000037:antagonists & inhibitors*
D000319:Adrenergic beta-Antagonists; D004791:Enzyme Inhibitors; D007211:Indoles; D008301:Maleimides; C099154:ruboxistaurin; D011493:Protein Kinase C